MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 4 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $627,000 | +29.8% | 246,745 | +3.7% | 0.00% | – |
| Q1 2020 | $483,000 | +71.3% | 237,907 | +82.5% | 0.00% | – |
| Q4 2019 | $282,000 | +40.3% | 130,390 | 0.0% | 0.00% | – |
| Q3 2019 | $201,000 | -64.7% | 130,390 | -4.9% | 0.00% | – |
| Q2 2019 | $569,000 | -6.0% | 137,060 | -5.3% | 0.00% | – |
| Q1 2019 | $605,000 | +100.3% | 144,669 | +37.4% | 0.00% | – |
| Q4 2018 | $302,000 | -72.7% | 105,291 | -4.7% | 0.00% | – |
| Q3 2018 | $1,105,000 | +46.6% | 110,480 | +3.7% | 0.00% | – |
| Q2 2018 | $754,000 | +438.6% | 106,560 | +190.4% | 0.00% | – |
| Q1 2018 | $140,000 | -48.3% | 36,697 | +10.5% | 0.00% | – |
| Q4 2017 | $271,000 | +111.7% | 33,209 | +52.0% | 0.00% | – |
| Q3 2017 | $128,000 | +255.6% | 21,842 | +8.0% | 0.00% | – |
| Q1 2017 | $36,000 | +71.4% | 20,229 | +22.8% | 0.00% | – |
| Q2 2016 | $21,000 | -76.4% | 16,474 | -0.4% | 0.00% | – |
| Q1 2016 | $89,000 | – | 16,535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,340,588 | $2,440,000 | 0.40% |
| ArrowMark Colorado Holdings LLC | 942,059 | $1,715,000 | 0.03% |
| A.R.T. Advisors, LLC | 39,100 | $71,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 52,432 | $95,000 | 0.02% |
| Orbimed Advisors | 567,600 | $1,033,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 15,697 | $29,000 | 0.01% |
| Palo Alto Investors LP | 63,517 | $116,000 | 0.01% |
| Virtu KCG Holdings LLC | 90,063 | $164,000 | 0.00% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 10,000 | $18,000 | 0.00% |
| FRANKLIN RESOURCES INC | 2,182,185 | $3,972,000 | 0.00% |